A 2019 study reveals further marginal decline in the pharma industry's reputation. Sven Klingemann suggests some "recovery solutions".
Sven Klingemann
Advertisement
Sven Klingemann, Ph.D, is a Research Director at Reputation Institute.
Articles by Sven Klingemann
Advertisement
Latest Updated Articles
Restoring Pharma's ReputationPublished: August 7th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
3
FDA Announces New Biosimilar-Targeted Draft Guidance
4
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
5
